BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025
• 2026

Month

• January
• February

Day

• 1
• 2
• 5
• 6
• 7
• 8
• 9
• 12
• 13
• 14
• 15
• 16
• 19
• 20
• 21
• 22
• 23
• 26
• 27
• 28
• 29
• 30

• Press Releases

  Vibrant Therapeutics Raises $61M and Appoints Han Lee, Ph.D. as Co-CEO

  January 12, 2026

   · 

  5 min read
• Press Releases

  Ono to Participate in the 44th Annual J.P. Morgan Healthcare Conference

  January 12, 2026

   · 

  1 min read
• Press Releases

  PharmaEssentia Announces Positive Topline Phase 2b Data from EXCEED-ET Study Evaluating Ropeginterferon Alfa-2b-njft for Essential Thrombocythemia

  January 12, 2026

   · 

  9 min read
• Press Releases

  GeneDx Announces Preliminary 2025 Financial Results and Provides 2026 Guidance

  January 12, 2026

   · 

  11 min read
• Press Releases

  ConcertAI and Foundation Medicine Integrate Genomic and Clinical Data to Transform Translational Research and Efficient Drug Development

  January 12, 2026

   · 

  5 min read
• Press Releases

  Atara Biotherapeutics Provides Regulatory and Business Update on EBVALLO™ (tabelecleucel)

  January 12, 2026

   · 

  7 min read
• Press Releases

  IND Amendment Clearance Obtained for Clinical Manufacturing of Rese-Cel from Cabaletta Bio Using Cellares’ Automated Platforms

  January 12, 2026

   · 

  5 min read
• Press Releases

  Mirador Accelerates Multi-Asset Clinical Pipeline in Immuno-Fibrotic Disease; Closes $250 Million Series B with Premier Investors

  January 12, 2026

   · 

  3 min read
• Press Releases

  Dispatch Bio Announces FDA Clearance of IND Application for DISP-10, a First-in-Class Immunotherapy Treatment, in Solid Tumors

  January 12, 2026

   · 

  3 min read
• Press Releases

  Wilmington PharmaTech Appoints Seasoned Commercial Leader to Drive Growth

  January 12, 2026

   · 

  3 min read